218 related articles for article (PubMed ID: 10775108)
21. Prevention of insulin-dependent diabetes mellitus in nonobese diabetic mice by immunogenic but not by tolerated peptides.
Vaysburd M; Lock C; McDevitt H
J Exp Med; 1995 Sep; 182(3):897-902. PubMed ID: 7650494
[TBL] [Abstract][Full Text] [Related]
22. Detection of glutamic acid decarboxylase-activated T cells with I-Ag7 tetramers.
Liu CP; Jiang K; Wu CH; Lee WH; Lin WJ
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14596-601. PubMed ID: 11106373
[TBL] [Abstract][Full Text] [Related]
23. The role of MHC class II molecules in susceptibility to type I diabetes: identification of peptide epitopes and characterization of the T cell repertoire.
Chao CC; Sytwu HK; Chen EL; Toma J; McDevitt HO
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9299-304. PubMed ID: 10430937
[TBL] [Abstract][Full Text] [Related]
24. MHC class II Ab diabetogenic residue 57 Asp/non-Asp dimorphism influences T-cell recognition and selection.
Antoniou AN; Elliott J; Rosmarakis E; Dyson PJ
Immunogenetics; 1998; 47(3):218-25. PubMed ID: 9435340
[TBL] [Abstract][Full Text] [Related]
25. Structures of an MHC class II molecule with covalently bound single peptides.
Fremont DH; Hendrickson WA; Marrack P; Kappler J
Science; 1996 May; 272(5264):1001-4. PubMed ID: 8638119
[TBL] [Abstract][Full Text] [Related]
26. Self peptides isolated from MHC glycoproteins of non-obese diabetic mice.
Reich EP; von Grafenstein H; Barlow A; Swenson KE; Williams K; Janeway CA
J Immunol; 1994 Mar; 152(5):2279-88. PubMed ID: 8133041
[TBL] [Abstract][Full Text] [Related]
27. Immunization with an insulin peptide-MHC complex to prevent type 1 diabetes of NOD mice.
Zhang L; Stadinski BD; Michels A; Kappler JW; Eisenbarth GS
Diabetes Metab Res Rev; 2011 Nov; 27(8):784-9. PubMed ID: 22069260
[TBL] [Abstract][Full Text] [Related]
28. Beta 57-Asp plays an essential role in the unique SDS stability of HLA-DQA1*0102/DQB1*0602 alpha beta protein dimer, the class II MHC allele associated with protection from insulin-dependent diabetes mellitus.
Ettinger RA; Liu AW; Nepom GT; Kwok WW
J Immunol; 2000 Sep; 165(6):3232-8. PubMed ID: 10975839
[TBL] [Abstract][Full Text] [Related]
29. Identification of immunogenic epitopes of GAD 65 presented by Ag7 in non-obese diabetic mice.
Chao CC; McDevitt HO
Immunogenetics; 1997; 46(1):29-34. PubMed ID: 9148785
[TBL] [Abstract][Full Text] [Related]
30. Conformation of MHC class II I-A(g7) is sensitive to the P9 anchor amino acid in bound peptide.
Gardiner A; Richards KA; Sant AJ; Arneson LS
Int Immunol; 2007 Sep; 19(9):1103-13. PubMed ID: 17855434
[TBL] [Abstract][Full Text] [Related]
31. Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice.
Judkowski V; Pinilla C; Schroder K; Tucker L; Sarvetnick N; Wilson DB
J Immunol; 2001 Jan; 166(2):908-17. PubMed ID: 11145667
[TBL] [Abstract][Full Text] [Related]
32. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401.
Wicker LS; Chen SL; Nepom GT; Elliott JF; Freed DC; Bansal A; Zheng S; Herman A; Lernmark A; Zaller DM; Peterson LB; Rothbard JB; Cummings R; Whiteley PJ
J Clin Invest; 1996 Dec; 98(11):2597-603. PubMed ID: 8958223
[TBL] [Abstract][Full Text] [Related]
33. A new model defines the minimal set of polymorphism in HLA-DQ and -DR that determines susceptibility and resistance to autoimmune diabetes.
Parry CS; Brooks BR
Biol Direct; 2008 Oct; 3():42. PubMed ID: 18854049
[TBL] [Abstract][Full Text] [Related]
34. A peptide-binding motif for I-A(g7), the class II major histocompatibility complex (MHC) molecule of NOD and Biozzi AB/H mice.
Harrison LC; Honeyman MC; Trembleau S; Gregori S; Gallazzi F; Augstein P; Brusic V; Hammer J; Adorini L
J Exp Med; 1997 Mar; 185(6):1013-21. PubMed ID: 9091575
[TBL] [Abstract][Full Text] [Related]
35. HLA-DR53 molecules restrict glutamic acid decarboxylase peptide presentation to T cells of a Type I diabetes patient: specification of the trimolecular HLA-peptide/T-cell receptor complex.
Huck C; Endl J; Walk T; Noessner E; Jung G; Wank R; Schendel DJ
Diabetologia; 2001 Jan; 44(1):70-80. PubMed ID: 11206414
[TBL] [Abstract][Full Text] [Related]
36. Biochemical characterization of the human diabetes-associated HLA-DQ8 allelic product: similarity to the major histocompatibility complex class II I-A(g)7 protein of non-obese diabetic mice.
Reizis B; Altmann DM; Cohen IR
Eur J Immunol; 1997 Oct; 27(10):2478-83. PubMed ID: 9368599
[TBL] [Abstract][Full Text] [Related]
37. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes.
Lee KH; Wucherpfennig KW; Wiley DC
Nat Immunol; 2001 Jun; 2(6):501-7. PubMed ID: 11376336
[TBL] [Abstract][Full Text] [Related]
38. A conformationally-constrained MHC class II I-Ag7-derived peptide protects NOD mice from the development of diabetes.
Dunsavage MB; O'Leary CJ; Baumgart TD; Solvason N; Howard M; Lafferty K; Deshpande S; Reich EP
J Autoimmun; 1999 Jun; 12(4):233-42. PubMed ID: 10330294
[TBL] [Abstract][Full Text] [Related]
39. High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease.
Bach JM; Otto H; Nepom GT; Jung G; Cohen H; Timsit J; Boitard C; van Endert PM
J Autoimmun; 1997 Aug; 10(4):375-86. PubMed ID: 9237801
[TBL] [Abstract][Full Text] [Related]
40. Identification of peptides from autoantigens GAD65 and IA-2 that bind to HLA class II molecules predisposing to or protecting from type 1 diabetes.
Harfouch-Hammoud E; Walk T; Otto H; Jung G; Bach JF; van Endert PM; Caillat-Zucman S
Diabetes; 1999 Oct; 48(10):1937-47. PubMed ID: 10512357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
